Quality of life in patients with uveitis: data from the ULISSE study (Uveitis: cLInical and medico-economic evaluation of a Standardised Strategy for the Etiological diagnosis)

Affiliation auteurs!!!! Error affiliation !!!!
TitreQuality of life in patients with uveitis: data from the ULISSE study (Uveitis: cLInical and medico-economic evaluation of a Standardised Strategy for the Etiological diagnosis)
Type de publicationJournal Article
Year of Publication2021
AuteursBertrand P-jean, Jamilloux Y, Kodjikian L, Errera M-H, Perard L, Pugnet G, Tieulie N, Andre M, Bielefeld P, Bron AM, Decullier E, Bin S, Seve P
JournalBRITISH JOURNAL OF OPHTHALMOLOGY
Volume105
Pagination935-940
Date PublishedJUL
Type of ArticleArticle
ISSN0007-1161
Mots-clésImmunology, inflammation, Vision
Résumé

Aims To assess vision-related (VR-QOL) and health-related quality of life (HR-QOL) in a large series of patients with de novo uveitis at baseline and 6-month follow-up. Methods Non-inferiority, prospective, multicentre, cluster randomised controlled trial registered under the Unique Identifier: NCT01162070. VR-QOL and HR-QOL were assessed by the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25) and the Medical Outcomes Study 36-item Short Form Survey (SF-36). Results At inclusion, 466 patients completed the VFQ-25. The mean composite score was 80.0 (+/- 16.7). In multivariate analysis, higher age, female sex and insidious onset were significantly associated with lower QOL. At 6 months, 138 patients completed the VFQ-25, with a significantly higher mean composite score of 82.6 (+/- 16.7). SF-36 mental component was 42.9 (+/- 11.3) and physical component was 47.2 (+/- 8.5) at inclusion (n=425). HR-QOL improvement at 6 months was not clinically significant. Conclusion QOL seems relatively well preserved in this cohort; only VR-QOL improved significantly at 6 months, especially in patients with low initial visual acuity.

DOI10.1136/bjophthalmol-2020-315862